AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Ardent Health Inc.

$10.95 +$2.31 (+26.74%)
NYSE · 14 Sep 2026 14:58 UTC
Previous Close
$10.98
Day Range
$10.9$11.28
Year Range
$7.71$15.48
Market Cap
1.57B
AVG Volume
507.83K
Trailing/Forward PE
19.91/9.4
PEG ratio
0.91
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q21.62B
26 Q11.6B
25 Q41.61B
25 Q31.58B
25 Q21.65B
25 Q11.5B
24 Q41.61B
24 Q31.45B
24 Q21.47B
24 Q11.44B
Net Income (USD)
-50M050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q216.9M
26 Q139.85M
25 Q444.96M
25 Q3-23.48M
25 Q272.95M
25 Q141.38M
24 Q4114.2M
24 Q326.32M
24 Q242.77M
24 Q127.05M
Operating Income (USD)
-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q243.2M
26 Q180.91M
25 Q4104.75M
25 Q3254.33M
25 Q2137.28M
25 Q167.09M
24 Q4336.79M
24 Q370.38M
24 Q2-157.41M
24 Q175.83M
EBITDA (USD)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q271.98M
26 Q1128.32M
25 Q4145.79M
25 Q355.61M
25 Q2176.03M
25 Q1124.58M
24 Q4195.43M
24 Q3108.47M
24 Q2136.66M
24 Q1108.96M
Cash Flows (USD)
-100M0100M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2158.06M
26 Q1-88.31M
25 Q4137.83M
25 Q393M
25 Q271.29M
25 Q1-47.7M
24 Q438.3M
24 Q348.68M
24 Q279.07M
24 Q1-38.53M
EPS (USD)
-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.12
26 Q10.28
25 Q40.32
25 Q3-0.17
25 Q20.52
25 Q10.29
24 Q40.86
24 Q30.19
24 Q20.3
24 Q10.19
Expenses (USD)
0500M1B1.5BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q238.68M
26 Q128.09M
25 Q4460.23M
25 Q3704.26M
25 Q21.08B
25 Q11.03B
24 Q4696.8M
24 Q31.02B
24 Q2996.84M
24 Q1972.1M
Cash & Debt (USD)
0500M1B1.5BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2724.48M
26 Q1609.69M
25 Q4709.6M
25 Q3609.44M
25 Q2540.63M
25 Q1495.04M
24 Q4556.78M
24 Q3563.14M
24 Q2334.54M
24 Q1372.77M
Debt ratios
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Debt ratios by quarter
PeriodDebt ratios
26 Q23.84
26 Q13.31
25 Q43.1
25 Q33.02
25 Q22.86
25 Q13.15
24 Q43.14
24 Q34.06
24 Q24.69
24 Q15.13
Margins
0%25%50%75%100%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Margins by quarter
PeriodMargins
26 Q25.99%
26 Q115.36%
25 Q442.13%
25 Q357.07%
25 Q283.55%
25 Q182.71%
24 Q459.29%
24 Q382.63%
24 Q282.37%
24 Q182.09%
Return on Capital
-2.5%0%2.5%5%7.5%10%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Return on Capital by quarter
PeriodReturn on Capital
26 Q20.97%
26 Q12.3%
25 Q42.67%
25 Q3-1.44%
25 Q24.43%
25 Q12.65%
24 Q47.5%
24 Q31.9%
24 Q23.68%
24 Q12.43%
Shares Outstanding
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2141.69M
26 Q1141.27M
25 Q4140.76M
25 Q3140.57M
25 Q2140.22M
25 Q1140.06M
24 Q4142.75M
24 Q3137.11M
24 Q2142.76M
24 Q1143.26M
Book Value Per Share (USD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q212.32
26 Q112.26
25 Q411.97
25 Q311.61
25 Q211.74
25 Q111.17
24 Q410.66
24 Q310.12
24 Q28.14
24 Q17.78
Total Assets (USD)
02B4B6B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ARDT Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q25.28B
26 Q15.25B
25 Q45.29B
25 Q35.15B
25 Q25.03B
25 Q14.91B
24 Q44.96B
24 Q34.8B
24 Q24.61B
24 Q14.59B
Employee Count
05K10K15K20K20242025
ARDT Employee Count by quarter
PeriodEmployee Count
202519.5K
202419.2K
PE Ratio
010203040med 9Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT PE Ratio by quarter
PeriodPE Ratio
Sep 2619.89
Sep 2619.76
Aug 2619.85
Aug 2619.91
Aug 2619.76
Aug 2612.15
Jul 2611.23
Jul 2611.19
Jul 2610.68
Jul 2610.6
Jul 2611.32
Jun 2610.24
Jun 269.37
Jun 269.84
Jun 269.13
May 269.71
May 269.71
May 2610.63
May 2610.64
May 2610.52
Apr 2610.04
Apr 2610.27
Apr 269.74
Apr 268.98
Mar 268.9
Mar 268.78
Mar 266.44
Mar 266.1
Feb 266.44
Feb 266.45
Feb 266.58
Feb 266.13
Jan 265.6
Jan 265.87
Jan 265.9
Jan 266.08
Jan 265.92
Dec 256.32
Dec 256.04
Dec 256.03
Dec 256.03
Nov 256.02
Nov 256.13
Nov 256.18
Nov 257.92
Oct 258.01
Oct 258.37
Oct 258.05
Oct 257.73
Oct 257.71
Sep 257.3
Sep 257.05
Sep 257.2
Sep 257.24
Aug 256.98
Aug 257.14
Aug 256.87
Aug 256.54
Aug 256.37
Jul 256.89
Jul 256.93
Jul 258.83
Jul 258.35
Jun 258.53
Jun 258.13
Jun 258.2
Jun 259.26
May 259.03
May 259.11
May 259.61
May 259.05
May 258.94
Apr 258.5
Apr 258.49
Apr 257.99
Apr 258.28
Mar 258.96
Mar 258.92
Mar 259.43
Mar 259.89
Feb 259.95
Feb 2520.72
Feb 2522.02
Feb 2522.36
Jan 2522.36
Jan 2521.24
Jan 2521.02
Jan 2523.55
Jan 2524.8
Dec 2425.2
Dec 2423.86
Dec 2424.88
Dec 2424.82
Nov 2423.82
Nov 2423.6
Nov 2424.76
Nov 2424.4
Nov 2429.21
Oct 2429.28
Oct 2432.25
Free Cash Flow Yield
0%5%10%15%20%25%med 7.14%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 2619.32%
Sep 2619.44%
Aug 2619.36%
Aug 2619.3%
Aug 2619.44%
Aug 2613.1%
Jul 2614.18%
Jul 2614.22%
Jul 2614.91%
Jul 2615.01%
Jul 2614.07%
Jun 2615.56%
Jun 2616.99%
Jun 2616.19%
Jun 2617.44%
May 2616.4%
May 2616.4%
May 2614.99%
May 2614.97%
May 2617.81%
Apr 2618.65%
Apr 2618.24%
Apr 2619.23%
Apr 2620.87%
Mar 2621.04%
Mar 2621.34%
Mar 2611.73%
Mar 2612.38%
Feb 2611.73%
Feb 2611.71%
Feb 2611.48%
Feb 2612.33%
Jan 2613.49%
Jan 2612.87%
Jan 2612.81%
Jan 2612.42%
Jan 2612.75%
Dec 2511.95%
Dec 2512.51%
Dec 2512.54%
Dec 2512.54%
Nov 2512.55%
Nov 2512.33%
Nov 2512.23%
Nov 255.48%
Oct 255.42%
Oct 255.18%
Oct 255.39%
Oct 255.61%
Oct 255.62%
Sep 255.95%
Sep 256.15%
Sep 256.03%
Sep 255.99%
Aug 256.21%
Aug 256.08%
Aug 256.32%
Aug 256.63%
Aug 258.27%
Jul 257.64%
Jul 257.61%
Jul 255.96%
Jul 256.31%
Jun 256.18%
Jun 256.48%
Jun 256.43%
Jun 255.69%
May 255.84%
May 255.78%
May 255.48%
May 255.82%
May 256.78%
Apr 257.14%
Apr 257.14%
Apr 257.58%
Apr 257.32%
Mar 256.77%
Mar 256.8%
Mar 256.43%
Mar 256.13%
Feb 256.09%
Feb 255.21%
Feb 254.9%
Feb 254.83%
Jan 254.83%
Jan 255.08%
Jan 255.14%
Jan 254.58%
Jan 254.35%
Dec 244.28%
Dec 244.52%
Dec 244.34%
Dec 244.35%
Nov 244.53%
Nov 244.57%
Nov 244.36%
Nov 244.42%
Nov 244.52%
Oct 244.51%
Oct 244.1%
Price to Sales
0.10.20.30.40.5med 0.28Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT Price to Sales by quarter
PeriodPrice to Sales
Sep 260.24
Sep 260.24
Aug 260.24
Aug 260.24
Aug 260.24
Aug 260.25
Jul 260.23
Jul 260.23
Jul 260.22
Jul 260.22
Jul 260.24
Jun 260.21
Jun 260.2
Jun 260.21
Jun 260.19
May 260.2
May 260.2
May 260.22
May 260.22
May 260.23
Apr 260.22
Apr 260.22
Apr 260.21
Apr 260.19
Mar 260.19
Mar 260.19
Mar 260.21
Mar 260.2
Feb 260.21
Feb 260.21
Feb 260.21
Feb 260.2
Jan 260.18
Jan 260.19
Jan 260.19
Jan 260.2
Jan 260.19
Dec 250.2
Dec 250.2
Dec 250.2
Dec 250.2
Nov 250.2
Nov 250.2
Nov 250.2
Nov 250.33
Oct 250.33
Oct 250.34
Oct 250.33
Oct 250.32
Oct 250.32
Sep 250.3
Sep 250.29
Sep 250.3
Sep 250.3
Aug 250.29
Aug 250.29
Aug 250.28
Aug 250.27
Aug 250.24
Jul 250.26
Jul 250.26
Jul 250.33
Jul 250.31
Jun 250.32
Jun 250.3
Jun 250.31
Jun 250.35
May 250.34
May 250.34
May 250.36
May 250.34
May 250.32
Apr 250.3
Apr 250.3
Apr 250.28
Apr 250.29
Mar 250.32
Mar 250.31
Mar 250.33
Mar 250.35
Feb 250.35
Feb 250.33
Feb 250.35
Feb 250.36
Jan 250.36
Jan 250.34
Jan 250.34
Jan 250.38
Jan 250.4
Dec 240.41
Dec 240.38
Dec 240.4
Dec 240.4
Nov 240.38
Nov 240.38
Nov 240.4
Nov 240.39
Nov 240.45
Oct 240.45
Oct 240.5
EV/EBITDA
4681012med 6.22Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 267.71
Sep 267.69
Aug 267.7
Aug 267.71
Aug 267.69
Aug 266.54
Jul 266.29
Jul 266.29
Jul 266.15
Jul 266.13
Jul 266.32
Jun 266.03
Jun 265.8
Jun 265.93
Jun 265.74
May 265.89
May 265.89
May 266.14
May 266.14
May 265.94
Apr 265.81
Apr 265.88
Apr 265.73
Apr 265.53
Mar 265.51
Mar 265.47
Mar 265.41
Mar 265.29
Feb 265.41
Feb 265.42
Feb 265.47
Feb 265.3
Jan 265.1
Jan 265.2
Jan 265.21
Jan 265.28
Jan 265.22
Dec 255.37
Dec 255.27
Dec 255.26
Dec 255.26
Nov 255.26
Nov 255.3
Nov 255.32
Nov 256.2
Oct 256.23
Oct 256.38
Oct 256.25
Oct 256.11
Oct 256.11
Sep 255.93
Sep 255.83
Sep 255.89
Sep 255.91
Aug 255.8
Aug 255.87
Aug 255.75
Aug 255.61
Aug 255.68
Jul 255.89
Jul 255.91
Jul 256.66
Jul 256.47
Jun 256.54
Jun 256.38
Jun 256.41
Jun 256.83
May 256.74
May 256.78
May 256.97
May 256.75
May 256.56
Apr 256.39
Apr 256.39
Apr 256.2
Apr 256.31
Mar 256.57
Mar 256.55
Mar 256.75
Mar 256.93
Feb 256.95
Feb 258.64
Feb 258.92
Feb 259
Jan 259
Jan 258.75
Jan 258.7
Jan 259.26
Jan 259.54
Dec 249.63
Dec 249.33
Dec 249.56
Dec 249.54
Nov 249.32
Nov 249.27
Nov 249.53
Nov 249.45
Nov 2410.88
Oct 2410.89
Oct 2411.52
Price/Operating Cashflow
2.557.51012.5med 5.6Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 263.05
Sep 263.03
Aug 263.04
Aug 263.05
Aug 263.03
Aug 263.79
Jul 263.5
Jul 263.49
Jul 263.33
Jul 263.3
Jul 263.53
Jun 263.19
Jun 262.92
Jun 263.07
Jun 262.85
May 263.03
May 263.03
May 263.31
May 263.31
May 263.06
Apr 262.92
Apr 262.99
Apr 262.84
Apr 262.61
Mar 262.59
Mar 262.56
Mar 263.63
Mar 263.44
Feb 263.63
Feb 263.63
Feb 263.71
Feb 263.45
Jan 263.15
Jan 263.31
Jan 263.32
Jan 263.42
Jan 263.34
Dec 253.56
Dec 253.4
Dec 253.39
Dec 253.39
Nov 253.39
Nov 253.45
Nov 253.48
Nov 256.63
Oct 256.71
Oct 257.01
Oct 256.74
Oct 256.47
Oct 256.46
Sep 256.11
Sep 255.9
Sep 256.02
Sep 256.06
Aug 255.85
Aug 255.98
Aug 255.75
Aug 255.48
Aug 254.69
Jul 255.08
Jul 255.1
Jul 256.51
Jul 256.15
Jun 256.28
Jun 255.99
Jun 256.04
Jun 256.83
May 256.65
May 256.72
May 257.08
May 256.67
May 255.97
Apr 255.67
Apr 255.67
Apr 255.34
Apr 255.53
Mar 255.98
Mar 255.95
Mar 256.29
Mar 256.61
Feb 256.64
Feb 257.25
Feb 257.7
Feb 257.82
Jan 257.82
Jan 257.43
Jan 257.35
Jan 258.24
Jan 258.68
Dec 248.82
Dec 248.35
Dec 248.7
Dec 248.68
Nov 248.33
Nov 248.25
Nov 248.66
Nov 248.54
Nov 249.74
Oct 249.76
Oct 2410.75
Price to Book
0.511.522.5med 1.09Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ARDT Price to Book by quarter
PeriodPrice to Book
Sep 260.89
Sep 260.89
Aug 260.89
Aug 260.89
Aug 260.89
Aug 260.94
Jul 260.87
Jul 260.87
Jul 260.83
Jul 260.82
Jul 260.88
Jun 260.79
Jun 260.73
Jun 260.76
Jun 260.71
May 260.75
May 260.75
May 260.82
May 260.82
May 260.85
Apr 260.81
Apr 260.83
Apr 260.79
Apr 260.72
Mar 260.72
Mar 260.71
Mar 260.81
Mar 260.77
Feb 260.81
Feb 260.81
Feb 260.83
Feb 260.77
Jan 260.7
Jan 260.74
Jan 260.74
Jan 260.76
Jan 260.74
Dec 250.79
Dec 250.76
Dec 250.76
Dec 250.76
Nov 250.76
Nov 250.77
Nov 250.78
Nov 251.23
Oct 251.24
Oct 251.3
Oct 251.25
Oct 251.2
Oct 251.19
Sep 251.13
Sep 251.09
Sep 251.11
Sep 251.12
Aug 251.08
Aug 251.11
Aug 251.06
Aug 251.01
Aug 250.91
Jul 250.99
Jul 250.99
Jul 251.27
Jul 251.2
Jun 251.22
Jun 251.17
Jun 251.18
Jun 251.33
May 251.3
May 251.31
May 251.38
May 251.3
May 251.23
Apr 251.17
Apr 251.17
Apr 251.1
Apr 251.14
Mar 251.24
Mar 251.23
Mar 251.3
Mar 251.37
Feb 251.37
Feb 251.37
Feb 251.46
Feb 251.48
Jan 251.48
Jan 251.41
Jan 251.39
Jan 251.56
Jan 251.65
Dec 241.67
Dec 241.58
Dec 241.65
Dec 241.65
Nov 241.58
Nov 241.56
Nov 241.64
Nov 241.62
Nov 242.17
Oct 242.18
Oct 242.4
Ardent Health Inc.
ARDT
Stockpicker

Video analysis: ARDT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARDT

Hsbc Holdings PLC Invests $543,000 in Ardent Health, Inc. $ARDT

defenseworld.net · 3 Sep 2026

Hsbc Holdings PLC Invests $543,000 in Ardent Health, Inc. $ARDT

Hsbc Holdings PLC bought a new position in Ardent Health, Inc. (NYSE: ARDT) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 55,280 shares of the company's stock, valued at approximately $543,000. A number of other institutional investors and hedge

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

businesswire.com · 2 Sep 2026

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

BRENTWOOD, Tenn. & TYLER, Texas--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, orthope.

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

businesswire.com · 27 Aug 2026

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the management team will participate in a fireside chat on September 9, 2026, at 11 a.m. ET. A live audio webcast of the event will be available in the Investor Relations sec.

Implied Volatility Surging for Ardent Health Stock Options

zacks.com · 13 Aug 2026

Implied Volatility Surging for Ardent Health Stock Options

Investors need to pay close attention to ARDT stock based on the movements in the options market lately.

Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region

businesswire.com · 11 Aug 2026

Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region

BRENTWOOD, Tenn. & TULSA, Okla.--(BUSINESS WIRE)--Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials – and recently became the first in the United States to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II clinical trial. Through this research, OHI is expanding acces.

New Strong Sell Stocks for August 7th

zacks.com · 7 Aug 2026

New Strong Sell Stocks for August 7th

ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.

Ardent Health Q2 Earnings Call Highlights

marketbeat.com · 5 Aug 2026

Ardent Health Q2 Earnings Call Highlights

Ardent Health NYSE: ARDT reported second-quarter revenue of $1.62 billion and adjusted EBITDA of $115 million, as management said cost controls, a favorable payer contract renewal and strong cash flow helped offset weaker-than-expected volumes.

Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

seekingalpha.com · 5 Aug 2026

Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

Ardent Health, Inc. (ARDT) Q2 2026 Earnings Call Transcript

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.